
The Urgent Need To Redefine the Future of UK Biotech
For decades, the narrative in life sciences has been simple: the U.S. is the promised land for biotech talent, while the U.K. is a promising, yet trailing, counterpart. This framing has been justified. With its deep pools of capital, aggressive risk …